Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Q32 Bio Inc (QTTB)

52 + Investors. Track Smart Money conviction in QTTB. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +3
Streak
1Q ▲
Buyers last Q
58%

Smart Money Signals — QTTB

Based on 52 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added QTTB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🔻

Below peak — only 58% of 3.0Y high

58% of all-time peak
Only 52 funds hold QTTB today versus a peak of 90 funds at 2024 Q4 — just 58% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 26% fewer funds vs a year ago

fund count last 6Q
18 fewer hedge funds hold QTTB compared to a year ago (-26% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟡

Slight buying edge — 58% buying

26 buying19 selling
Last quarter: 26 funds bought or added vs 19 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+6 vs last Q)

new funds entering per quarter
Funds opening a new QTTB position: 11 → 7 → 7 → 13. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 29% long-term, 29% new

■ 29% conviction (2yr+) ■ 42% medium ■ 29% new
Of the 52 current holders: 15 (29%) held >2 years, 22 held 1–2 years, and 15 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +122% but shares only +17% — price-driven

Value
+122%
Shares
+17%
Last quarter: the total dollar value of institutional holdings rose +122%, but actual share count only changed +17%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

10 → 11 → 7 → 7 → 13 new funds/Q
New funds entering each quarter: 11 → 7 → 7 → 13. A growing number of institutions are discovering QTTB each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
📊

Mixed cohorts — 4% veterans, 27% new entrants

■ 4% veterans ■ 69% 1-2yr ■ 27% new
Of 52 current holders: 2 (4%) held 2+ years, 36 held 1–2 years, 14 (27%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
📋

Smaller funds dominant — 3% AUM from top-100

3% from top-100 AUM funds
14 of 52 holders rank in the top 100 by AUM, but together hold only 3% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
1.6
out of 10
Low Exit Risk
Exit risk score 1.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — QTTB

In 2026 Q1, 26 hedge funds were net buyers of QTTB (13 opened a new position, 13 added to an existing one), while 19 reduced or exited (9 trimmed, 10 sold completely) — a 58% buyer ratio, indicating a slight buying edge. Net fund flow last quarter: +3 funds (more new holders than closures). Total institutional holders: 52.

Hedge Fund Ownership: QTTB

How many hedge funds hold QTTB — quarterly history vs. share price
Quarterly hedge fund ownership of QTTB vs. share price

Market Analysis: QTTB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: QTTB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Q32 Bio Inc (QTTB) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much QTTB has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
QTTB
+101.1%
XLV
+2.8%

QTTB outperformed XLV by +98.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
QTTB
+104.9%
XLV
+3.9%

Since the filing became public, QTTB outperformed XLV by +101.0% .

Interpretation: The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 0 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
0.6
/ 10
conviction
Hedge Fund Positioning: QTTB
52 + Investors

Track Smart Money conviction in QTTB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 52 49 6.12%
13F Shares 9M 8M 17.17%
Total Value $59M $27M 122.45%
New Positions 13 7 +6
Increased Positions 13 9 +4
Closed Positions 10 9 +1
Reduced Positions 9 18 -9
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: QTTB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

52 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in QTTB. Verified SEC 13F-HR filings.

QUARTER:
Top 25 QTTB holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Atlas Venture Life Science Advisors, LLC 1.70% 2,092,106 $13.4M
2 Opaleye Management Inc. 1.06% 1,256,228 $8.1M
3 Acorn Capital Advisors, LLC 0.57% 315,052 $2.0M
4 Sanofi 0.47% 244,083 $1.6M
5 Pfizer Inc 0.31% 101,618 $737K
6 ARCH Venture Management, LLC 0.30% 320,482 $2.1M
7 Orbimed Advisors LLC 0.29% 2,252,987 $14.5M
8 Monimus Capital Management, LP 0.24% 134,310 $862K
9 Carlyle Group Inc. 0.07% 1,102,741 $7.1M
10 ADAR1 Capital Management, LLC 0.01% 35,000 $225K
11 Affinity Asset Advisors, LLC 0.01% 27,777 $178K
12 Renaissance Technologies LLC 0.00% 206,915 $1.3M
13 Mackenzie Financial Corp 0.00% 246,304 $1.6M
14 Bridgeway Capital Management, LLC 0.00% 12,613 $81K
15 Marshall Wace, LLP 0.00% 52,440 $337K
16 Tower Research Capital LLC (TRC) 0.00% 1,871 $12K
17 Two Sigma Investments, LP 0.00% 42,346 $272K
18 Arax Advisory Partners 0.00% 1,148 $7K
19 Cetera Investment Advisers 0.00% 20,695 $133K
20 Vanguard Fiduciary Trust Co 0.00% 49,995 $321K
21 American Century Companies Inc 0.00% 18,770 $121K
22 Jane Street Group, LLC 0.00% 65,599 $421K
23 Vanguard Capital Management LLC 0.00% 306,401 $2.0M
24 Federated Hermes, INC. 0.00% 2,273 $15K
25 SBI Securities Co., Ltd. 0.00% 104 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Q32 Bio Inc (QTTB)

What does the Smart Money Trend signal show for QTTB?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added QTTB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for QTTB?

Slight buying edge — 58% buying: Last quarter: 26 funds bought or added vs 19 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for QTTB holders?

Smaller funds dominant — 3% AUM from top-100: 14 of 52 holders rank in the top 100 by AUM, but together hold only 3% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held QTTB?

Mixed — 29% long-term, 29% new: Of the 52 current holders: 15 (29%) held >2 years, 22 held 1–2 years, and 15 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Q32 Bio Inc (QTTB) following the 2026 Q1 hedge fund 13F filings?

As of today, QTTB has moved +104.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of +101.0%. Since the quarter end (March 31, 2026), QTTB has gained +101.1% vs +2.8% for XLV. The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →